Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Overview of attention for article published in OncoTargets and therapy, November 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 101 Dimensions

Readers on

mendeley: 129 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 101 publications that cite this research output.

101

The most recent citing publications are shown below. View all 101 publications that cite this research output on Dimensions.

Cancer invasion and anaerobic bacteria: new insights into mechanisms

Article in Journal of Medical Microbiology (March 2024)

Propolis-loaded nanostructured lipid carriers halt breast cancer progression through miRNA-223 related pathways: an in-vitro/in-vivo experiment

Article in Scientific Reports (September 2023)

Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery

Article in Frontiers in Oncology (July 2023)